Longboard Pharmaceuticals has commenced the Phase III DEEp OCEAN Study of its investigational oral drug bexicaserin for ...

Serotonin, also known as 5-hydroxytryptamine (5-HT), is a neurotransmitter (chemical messenger) that helps regulate various ...

Cognigenics’ initial therapeutics are designed to selectively downregulate the 5-hydroxytryptamine receptor 2A (5HT2A) post-synaptic neuronal receptors—a serotonin receptor subtype—in the ...

The focus is on bexicaserin, an oral 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist that targets Developmental and Epileptic Encephalopathies (DEEs), a group of severe epilepsies marked by ...

Psychedelic drugs can activate several biological targets, including 5-hydroxytryptamine (5-HT) 1A/2A receptors, 3,4-Methyl-enedioxy methamphetamine (MDMA), α-amino-3-hydroxy-5-methyl-4 ...

Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this ...

Although many studies were carried out to evaluate the role of melatonin in GERD based on its effect in alleviation of GERD symptoms only, the review of literature showed that no previous studies ...

Reported positive YTD 2024 Adjusted EBITDA of $1.4 million Company expects Q4 2024 Net Revenue in the range of $37 million - $43 million ZYNRELEF® (bupivacaine ...

International Symposium on Chemistry, Biology and Medicine. Paphos (Cyprus), 2006. “A Three-Dimensional Pharmacophore Model for 5-Hydroxytryptamine 6 (5-HT 6) Receptor Antagonists”, Journal of ...